Vanta Bioscience Limited (BOM:540729)

Market Cap	145.08M -7.6%
Revenue (ttm)	18.16M +61.1%
Net Income	1.08M
EPS	0.15
Shares Out	7.11M
PE Ratio	136.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,500
Open	20.40
Previous Close	20.42
Day's Range	20.40 - 20.40
52-Week Range	14.71 - 29.00
Beta	0.98
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Vanta Bioscience

Vanta Bioscience Limited, together with its subsidiaries, operates as a preclinical contract research organization in India. The company offers a range of services in method development, validation, impurity profiling, impurity isolation, characterization, certification and evaluation, mammalian and genetic toxicology, drug metabolism, pharmacokinetics, and bio-analysis during the preclinical stage of drug development. It also provides testing services for agrochemicals and chemicals, such as physico-chemical testing; sub-acute, sub-chronic, an...

• Industry: Commercial Physical and Biological Research
• Founded: 2016
• Employees: 38
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540729

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 24, 2026

Data Sources Report a data error